Conflict of interest DK has received research support from Sanofi, Tanabe Pharma, Terumo, Behringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Ono Pharmaceutical and Takeda Pharmaceutical as well as speaker honoraria from Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical
Were also working on a new drug called orforglipron, which is a nonpeptide GLP-1 agonist that is taken orally instead of by injection, which is not only more convenient for patients but also easier to produce
GLP1 Dose Calculator This tool was created to help you or your provider calculate the correct dose of GLP-1 medicationslike Mounjaro (tirzepatide)with ease and accuracy
Henry Meds semaglutide is a compounded medication, meaning it is mixed by specialized pharmacies rather than produced by an FDA-approved manufacturer